Latest Breaking News On - Neovascular age related macular degeneration - Page 1 : comparemela.com

Ikerian AG, Parent Company of RetinAI U S Inc Announces

RetinAI Medical AG rebranded as Ikerian AG “Ikerian”, to spearhead development beyond ophthalmology, with wholly-owned subsidiary RetinAI U.S. Inc..

United statesCarlos cillerSue charlesTopcon corporationTopcon healthcare incEuropean unionRetinai incBoehringer ingelheimRetinai us incCorporate venture capitalTopcon healthcareIndustrial technologiesMatterwave venturesVerve venturesReal world evidenceGeographic atrophy

Ikerian AG, Parent Company of RetinAI U S Inc Announces Final Close of USD 6 18M (CHF 5 65M) Series A Extension Financing

Ikerian AG, Parent Company of RetinAI U S Inc Announces Final Close of USD 6 18M (CHF 5 65M) Series A Extension Financing
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSue charlesCarlos cillerRetinai us incBoehringer ingelheimEuropean unionTopcon healthcare incParent company of retinai us incRetinai incTopcon corporationParent companyAnnounces final closeCorporate venture capitalTopcon healthcareIndustrial technologiesMatterwave ventures

Adverum Biotechnologies (ADVM) Reports Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial

Adverum Biotechnologies (ADVM) Reports Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomArshadm khananiLaurent fischerArshad khananiClinical research at sierra eye associatesClinical associate professor at university of nevadaExchange commissionMeeting of the macula societyHealthcare products regulatory agencyAdverum biotechnologies incAdverum biotechnologiesAnnual meetingIntravitreal gene therapyNeovascular age related macular degenerationPreliminary resultsManaging partner

Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial of Ixo-vec in Patients with Wet AMD

Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial of Ixo-vec in Patients with Wet AMD
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomArshad khananiArshadm khananiLaurent fischerClinical research at sierra eye associatesHealthcare products regulatory agencyClinical associate professor at university of nevadaAdverum biotechnologies incMeeting of the macula societyExchange commissionSafety dataAnnual meetingIntravitreal gene therapyNeovascular age related macular degenerationPreliminary resultsManaging partner

Adverum Biotechnologies will Host Webcast to Review LUNA Phase 2 Preliminary Efficacy and Safety Results on February 8, 2024

Adverum Biotechnologies will Host Webcast to Review LUNA Phase 2 Preliminary Efficacy and Safety Results on February 8, 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Arshadm khananiClinical research at sierra eye associatesMacula society meeting presentation informationReno school of medicineExchange commissionMeeting of the macula societyAdverum biotechnologies incClinical associate professor at university of nevadaMacula societyAnnual meetingSzilard kissWeill cornell medical collegeIntravitreal gene therapyNeovascular age related macular degenerationPreliminary resultsClinical research